Aclaris Therapeutics, Inc. (ACRS)
3.65
-0.04
(-1.08%)
USD |
NASDAQ |
Feb 10, 16:00
3.64
-0.01
(-0.27%)
After-Hours: 20:00
Aclaris Therapeutics EPS Diluted (Quarterly) : -0.1192 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 1.131 |
| PMV Pharmaceuticals, Inc. | -0.3974 |
| Atea Pharmaceuticals, Inc. | -0.5319 |
| Instil Bio, Inc. | -2.011 |
| Puma Biotechnology, Inc. | 0.1736 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.61M |
| Revenue (Quarterly) | 3.299M |
| Total Expenses (Quarterly) | 17.91M |
| Enterprise Value | 301.79M |
| Gross Profit Margin (Quarterly) | 25.77% |
| Profit Margin (Quarterly) | -443.0% |
| Earnings Yield | -37.85% |
| Normalized Earnings Yield | -20.29 |